Portfolio

Peptobiotics

Synthetic biology alternative to livestock antibiotics

Technology Development

Business Development

Revenue

Exited

Founded

2021

CEO
Jonathan Bester
UN SDGs
3
12
15
Contact Us
email
Follow Us
linkedin
Investors
Trendlines Agrifood Fund, Hatch Blue, Seventure Partners, Ponderosa, The Yield Lab, Genedan and others

About

Peptobiotics makes agriculture more productive, humane and sustainable by promoting growth and protecting against pathogens using a new type of antibiotic alternative. By leveraging advances in human medicine and synthetic biology, we are creating a new class of feed additives that can maximize animal welfare, gut health, feed conversion and growth with comparable performance to antibiotics – but without creating drug-resistant superbugs.

Market Need

For decades, farmers have relied on antibiotics not only to keep animals healthy and safe from disease, but also as gut health enhancing growth promoters to enable the production of more protein using less environmental inputs.

The overuse of antibiotics has been shown to result in increasing resistance to antibiotics amongst human pathogens. Antibiotic resistant bacterial result in >700,000 human deaths every year. Moving away from antibiotics is essential. But current alternatives lack efficacy and are too expensive.

Skip to content